Share this:
Research shows that metabolic surgery and GLP-1 medications are both effective therapies for treating obesity. Medications typically result in a 10% loss of body weight in a real-world setting, while surgery can achieve more dramatic results, up to 25% to 30%.
Metabolic experts at Mayo Clinic say combining the two in some instances can be an effective way to treat obesity.
Journalists: Broadcast-quality video (1:02) is in the downloads at the end of this post. Please courtesy: "Mayo Clinic News Network." Read the script.
"Obesity is a disease, and to overcome it, we need to use all the modalities, or tools, we have available," says Dr. Omar Ghanem, a Mayo Clinic metabolic surgeon.
However, it's not a one-size-fits-all approach.
"Some patients might benefit only from medications, some patients might benefit only from surgery, but a portion of patients might benefit from the combined therapy," Dr. Ghanem says.
He says some patients experience greater weight loss when combining bariatric surgery, also called metabolic surgery, with GLP-1 medications. Ideal candidates include patients who start obesity treatment with a higher body mass index, those who are preparing to undergo a complex surgical procedure, such as a transplant, and patients who need to lose more weight for their overall health or those looking to maintain their weight after metabolic surgery.
"Neither GLP-1s nor bariatric surgery are magic. These are tools, and the patient has to use those tools correctly to be able to overcome obesity," Dr. Ghanem says. "Each case is different. Go to your provider, talk to your specialist, and trust them to help you make the right decision for your health. Our patients have to put a lot of effort to overcome the disease. They're not just choosing the easy way out, they're choosing the healthy way out."
Related posts:
- Bariatric surgery paves way for heart transplant after end-stage heart failure
- New year, new focus on health: Mayo Clinic expert highlights effective treatment options for obesity
